Godrej Agrovet Ltd Q2FY26: EBITDA up 10%, PAT down 17%, SEBI warning letter, new CEO—agriculture meets corporate drama

“For educational and entertainment purposes, not investment advice, Check disclaimer”

Godrej Agrovet Ltd Q2FY26: EBITDA up 10%, PAT down 17%, SEBI warning letter, new CEO—agriculture meets corporate drama

1. At a Glance

Welcome toGodrej Agrovet Limited (GAVL)— India’s agri-conglomerate that milks cows, breeds chickens, squeezes oil palms, sprays crops, and somehow still has time to deal with SEBI warning letters. At ₹ 649 per share, the company commands amarket cap of ₹ 12,485 crore, but the recent 20% price fall in 3 months feels like watching your tractor slide on wet mud.

InQ2 FY26, revenue stood at ₹ 2,567 crore (+4.85% YoY), butPATdropped 17.6% to ₹ 92.6 crore.Operating marginsheld at 8%,ROE17.7%, andROCE16.6%. The balance sheet is stretched tighter than a farmer’s budget before harvest —debtrose from ₹ 1,400 crore to ₹ 1,923 crore as of Sep 2025.

Still, Godrej Agrovet isn’t your average mandi-trader. It’s the rare agribusiness that also throws a boardroom party when EBITDA margins touch 9%. But with the SEBI’s warning for delayed disclosures and a new CEO in the hot seat, the next quarter promises as much drama as a daily soap titledKhaad, Cow & Corporate Karma.

2. Introduction

Godrej Agrovet is that overachieving cousin in the Godrej family—busy running five different agribusinesses while juggling government MoUs, dairy expansions, and now, a SEBI slap on the wrist.

Founded on the noble mission of improving farmer productivity, it’s now a ₹ 10,000 crore+ machine operating from cattle feed to palm oil to pesticides to paneer. But despite its fancy R&D and premium Jersey milk ads, its stock performance has been as cold as that same Jersey milk left overnight.

In the past year, shareholders lost 10.5%, and in the last 3 months alone 20%. Meanwhile, management has been expanding into palm refineries, signing ₹ 960 crore MoUs, and bringing in a new CEO —Sunil Kataria, the ex-Godrej Consumer Products boss who knows a thing or two about turning soaps into gold.

The business is classic Godrej — heritage brand + R&D + diversification. But the real question: can this conglomerate balance milk, meat, and money without spilling any?

3. Business Model – WTF Do They Even Do?

If you ever wanted to invest in something that feeds cows, fattens chickens, crushes palm fruit, ferments milk, and sells pesticides — look no further.Godrej Agrovetis the buffet of Indian agribusiness.

Animal Feed (47%)– Their biggest revenue cow. They produce compound feed for cattle, poultry, fish, and shrimp. Even Bangladesh eats out of Godrej’s trough via their JV ACI Agrovet.

Dairy (17%)– Operated viaCreamline Dairy Productsunder theJerseybrand, selling everything from curd to lassi. They recently hiked their stake to 99.3%, so Jersey is now a full Godrej cow.

Vegetable Oil (14%)– India’s largest oil-palm processor with 30% market share. Think of them as “the Adani Wilmar of the south but with trees.” They work with 11,000 farmers managing 2 lakh hectares of plantations.

Crop Protection (13%)– Via subsidiaryAstec Lifesciences, they sell pesticides, fungicides, and regulators. Astec’s enterprise division had a bad year, proving that even chemicals can get depressed.

Poultry & Processed Foods (9%)– Their JV with Tyson Foods brings youReal Good ChickenandYummiez, the products that confuse vegetarians and excite gym-goers.

Together, this makes GAVL an agricultural Swiss-army knife: diversified, complex, and dangerous in the wrong hands.

4. Financials Overview

MetricLatest Qtr (Sep FY26)Same Qtr Last YearPrevious QtrYoY %QoQ %
Revenue (₹ cr)2,5672,4492,614+4.8−1.8
EBITDA (₹ cr)213223270−4.5−21.1
PAT (₹ cr)92.6112149−17.6−37.8
EPS (₹)4.85.88.4−17.6−42.6

Annualized EPS ≈ ₹ 19.2 → P/E ≈ 34×.

Commentary:Revenue up, profits down — the classic Indian corporate diet. Input costs and flat realizations hit margins, and management called it

“temporary.” Investors call it “permanent déjà vu.”

5. Valuation Discussion – Fair Value Range (Educational Only)

Let’s take three neutral lenses:

(a) P/E MethodEPS TTM = ₹ 22.6Industry P/E = 19× (Agro-FMCG average)

  • Optimistic case: 22.6 × 30 = ₹ 678
  • Base case: 22.6 × 25 = ₹ 565→ Fair Value Range: ₹ 565 – ₹ 680 per share

(b) EV/EBITDA MethodEV = ₹ 13,842 cr, EBITDA = ₹ 850 cr → EV/EBITDA ≈ 16×Industry average ≈ 14×If re-rated to 14× → EV = ₹ 11,900 cr → Implied equity ≈ ₹ 10,500 cr → ₹ 550 /share

(c) DCF (approx)FCF FY25 = ₹ 550 cr, growth 8%, WACC 10% → Fair Value ≈ ₹ 600 – ₹ 700

📘Disclaimer:This fair-value range (₹ 550 – ₹ 700) is purely for educational discussion, not investment advice.

6. What’s Cooking – News, Triggers, Drama

Because no Godrej quarter is complete without news, here’s the full platter:

  • New CEO Alert:Sunil Kataria (former GCPL CEO) took charge on 1 Sep 2025. Balram Yadav retires after 25 years of managing everything from feed mills to farm politics.
  • SEBI Warning Letter (29 Sep 2025):Astec Lifesciences delayed four regulatory disclosures by 2,725, 383, 39 and 11 days. SEBI sent a polite “don’t do it again.” Astec responded by not responding publicly at all.
  • MoU with MoFPI:₹ 960 crore investment to build five food-processing and R&D facilities by FY27. That’s right — they’re literally cooking growth.
  • Creamline Dairy:Godrej now owns 99.3% after buying 47% from promoters in Mar–May 2025. Expect more curd ads with less family drama.
  • Capex:New feed plant in Maharashtra (₹ 110 cr) and new oil-refinery (400 MTPD) under commissioning.
  • EBITDA Outlook:Mgmt guides for 9–10% margins despite global commodity madness.

In short, Q2 FY26

To Read Full 16 Point ArticleBecome a member
Become a member
To Read Full 16 Point ArticleBecome a member

Popular News

error: Content is protected !!